OSR Holdings (OSRH) Jumps Over 15% Today on Vaximm Deal Momentum: Stock Price, Nasdaq Risk and What Comes Next
OSR Holdings, Inc. is back on traders’ screens today, November 24, 2025, with the micro-cap healthcare stock extending last week’s rally sparked by its cancer-immunotherapy subsidiary Vaximm AG. As of early afternoon U.S. trading on Monday, OSRH is changing hands around $0.65, up roughly 15–16% versus Friday’s close near $0.56.Finviz The move builds on sharp gains posted after Vaximm announced a lucrative non‑binding term sheet with BCM Europe AG for its lead oral cancer vaccine platform, VXM01.PR Newswire+1